For $10 billion, Merck is acquiring a promising healthcare company which is in the early stages of its growth. Key to its ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Select Fund” second quarter 2025 investor letter. A copy ...

SINGAPORE] A surge in the value of private equity (PE) deals signed in India in the first half of this year, coupled with the ...

Indian equity benchmarks, Sensex and Nifty, traded lower on Thursday, mirroring subdued sentiment across Asian markets as ...

Boston Scientific stock, typically a strong performer, has been running in place for the last six months. Its second-quarter ...